Vet Times The website for the veterinary profession https://www.vettimes.co.uk

Diagnosing endocrine disease in

Author : Yvonne van Zeeland

Categories : Exotics, Vets

Date : November 1, 2016

ABSTRACT

Compared to mammals, , including parrots, seem to seldom suffer from endocrine disorders.

Hypoadrenocorticism and hyperadrenocorticism, as well as hyperthyroidism and thyroid neoplasia, have rarely been recognised in live birds. Hypothyroidism is suggested to occur more often, but, in many cases, lack of appropriate testing prevents a definite diagnosis from being made, thereby keeping the number of confirmed cases low.

Secondary nutritional hyperparathyroidism, on the other hand, is among the most common endocrine diseases seen in parrots, particularly in those fed diets low in calcium and/or vitamin D. Similarly, a poor calcium:phosphorus ratio may result in osteodystrophy or hypocalcaemia. Imbalanced diets may, furthermore, result in iodine deficiency and goitre, most commonly seen in budgerigars. Pituitary neoplasia and diabetes mellitus are also seen in this , but may occur in other species.

In many cases, antemortem diagnosis and treatment of endocrine disease remains challenging because of the limited pathophysiological knowledge, unavailability of validated tests and lack of information on appropriate dosing regimens in birds. However, by remaining alert to the possibility of a potential underlying endocrine disorder, and using the knowledge obtained from other companion , endocrine disease in parrots may be more readily recognised, diagnosed and treated.

In birds, the endocrine system consists of the hypothalamic-pituitary complex and pineal gland, carotid bodies, the thyroid, parathyroid, ultimobranchial and adrenal glands, the pancreas and endocrine cells of the gastrointestinal tract, and the gonads (Ritchie and Pilny, 2008; Orosz, 2016).

1 / 14 All of these organs secrete hormones into the bloodstream that help to maintain homeostasis and regulate internal processes, such as growth and development, metabolism, and reproductive activity.

Disease usually occurs as a result of a hypofunction or hyperfunction of the gland.

Endocrine diseases do occur in psittacine birds, but their incidence appears to be relatively low – most of the available information is derived from single case reports or small case series.

However, the low incidence may, in part, be explained by the lack of knowledge and appropriate tests to diagnose endocrine abnormalities.

As a result, endocrine disease might occur more often and should not be ruled out when compiling a differential diagnosis.

Of the various endocrine diseases that have been reported in parrots, secondary nutritional hyperparathyroidism, resulting in hypocalcaemia and/or metabolic bone disease, appears most common, especially in birds fed an all-seed diet (Stanford et al, 2013).

Similarly, goitre may be seen, most frequently in budgerigars, as a result of iodine deficiency (Schmidt, 2002). Other endocrine diseases appear less common in parrots, with reports of their incidence being limited to a single or small number of birds.

Pituitary gland diseases

2 / 14 Figure 1. Blue fronted Amazon with obesity and poor feather condition, suggestive of hypothyroidism.

The pituitary gland, also referred to as the hypophysis, is at the base of the brain, just below the hypothalamus.

It consists of an anterior part (adenohypophysis) and posterior part (neurohypophysis) that both produce and secrete hormones, such as (Ritchie and Pilny, 2008; Orosz, 2016):

luteinising hormone [LH] follicle stimulating hormone [FSH] thyroid stimulating hormone [TSH] adrenocorticotropic hormone [ACTH] growth hormone [GH] prolactin by the adenohypophysis arginine vasotocin [AVT] mesotocin by the neurohypophysi

Disease may occur as a result of various processes, most commonly as a result of a (benign) neoplastic growth.

Such pituitary tumours have most commonly been described in budgerigars (Schlumberger, 1954; Bauck, 1988; Langohr et al, 2012), but may also occur in other species (Curtis-Velasco, 1992;

3 / 14 Latimer, 1994; Lumeij, 1994; Romagnano et al, 1995; Starkey et al, 2008).

Generally, clinical signs will develop as a result of the mass pressing against the surrounding tissues, thereby causing neurological signs, exophthalmos and/or blindness (De Matos and Monks, 2016).

Similarly, pressure against the normal pituitary cells may result in hyposecretion of one or more of the pituitary hormones. Occasionally, hypersecretion of a specific hormone may be noted, leading to clinical signs of, for example, Cushing’s disease (as a result of overproduction of ACTH; Starkey et al, 2008) or diabetes insipidus (as a result of overproduction of AVT; Starkey et al, 2010).

A presumptive diagnosis can be made based on the clinical signs and ruling out of other diseases, but definite diagnosis requires visualisation of the pituitary mass using advanced imaging techniques, such as CT or MRI.

In addition, hormonal hypersecretion may be detected using hormone-specific assays or function tests (for example, water deprivation test; Alberts et al, 1988; Lumeij and Westerhof, 1988; Starkey et al, 2010).

However, size of the patient and tumour may prevent antemortem diagnosis of the tumour, thereby rendering postmortem examination as the only option to obtain a final diagnosis.

Thus far, no treatment has been reported for these types of tumours, although one report has demonstrated long-term management of central diabetes insipidus in a parrot using desmopressin (Starkey et al, 2010).

Thyroid gland diseases

Disease of the thyroid gland may result from hyperplasia, neoplasia, infection, inflammation or atrophy, with clinical signs occurring as a result of enlargement, hypofunction or hyperfunction of the gland (De Matos and Monks, 2016).

The number of documented cases of thyroid tumours and hyperthyroidism in psittacine birds is scarce, with most cases involving non-functional thyroid adenomas or adenocarcinomas (Lumeij, 1994; Rae, 1995; Doukaki et al, 2014).

Clinical signs will usually result by the tumour compressing the surrounding tissue and may include (Lumeij, 1994; Rae, 1995; Doukaki et al, 2014):

dyspnoea regurgitation dysphagia

4 / 14 These clinical signs may more commonly be observed, especially in budgerigars (Schmidt, 2002) in cases of thyroid hyperplasia (goitre). This disease, which is most often caused by an iodine deficiency, is usually diagnosed based on the history, clinical signs and response to dietary iodine supplementation (Lumeij, 1994).

Hypothyroidism has often been suspected as the cause of feather loss, due to a lack of feather growth, and obesity in parrots (Oglesbee, 1992; Kritchevsky, 2013; Figure 1). In many cases, diagnosis was based on the finding of low plasma T4 and/or a positive response to thyroxine supplementation (Lumeij, 1994; Oglesbee, 1992; De Matos and Monks, 2016).

However, definite diagnosis requires the use of a TSH stimulation test, with hypothyroid birds showing less than two-fold increases in plasma T4 levels compared to baseline (Lothrop et al, 1985a; Zenoble et al, 1985; Lumeij, 1994; Greenacre, 2011; De Matos and Monks, 2016).

In addition, scintigraphy may be helpful to diagnose hypothyroidism, but is not widely available (Harms et al, 1994).

Following confirmation of the diagnosis, treatment may be initiated with oral thyroxine supplementation (Oglesbee, 1992; De Matos and Monks, 2016).

Parathyroid gland diseases

Figure 2a. Young with a bent tibiotarsus resulting from osteodystrophy, developed as a result of low calcium intake and secondary nutritional hyperparathyroidism. IMAGE: Michael Stanford. (Click to zoom).

5 / 14 Thus far, disease of the parathyroid glands in birds has primarily been linked to hyperplasia resulting from dietary calcium, phosphorus and/or vitamin D deficiencies or imbalances (Stanford et al, 2013).

These dietary imbalances will, subsequently, result in a disturbance of the mineral homeostasis, which stimulates the parathyroid glands to produce more PTH to correct these imbalances (Stanford et al, 2013).

Grey parrots appear particularly prone to developing disease, potentially resulting from an increased dependency on UV light for their calcium metabolism (Stanford, 2006; Stanford et al, 2013). Clinical signs often include:

weakness ataxia tetany seizures

In young, growing birds, bone deformities and pathological fractures of the long bones and spinal column are frequently seen (Figures 2a and 2b), whereas female birds may present with egg binding, or production of poorly calcified or deformed eggs.

Diagnosis is usually based on low (ionised) calcium levels in the blood (Stanford, 2007), whereas radiographs may help diagnose bone abnormalities (Stanford et al, 2013; De Matos and Monks, 2016).

Treatment consists of oral and parenteral calcium and/or vitamin D3 supplementation, dietary corrections and exposure to UVB radiation through natural sunlight or artificial lighting (Stanford, 2004; Stanford et al, 2013).

Aside from hypocalcaemia, hypercalcaemia has been reported to occur in parrots. Most often, this is part of a physiological phenomenon in egg-laying females, with increased levels of oestrogen resulting in (Campbell-Ward, 2013):

increased calcium absorption in the gastrointestinal tract increased production of calcium-binding proteins (such as albumin) mobilisation of calcium from the medullary bone

Pathological hypercalcaemia also occurs, occasionally as a result of paraneoplastic syndromes in case of lymphoma (de Wit et al, 2003), but most commonly in response to long-term provision of a diet containing excessive amounts of calcium and/or vitamin D3 (Schoemaker et al, 1997; Campbell-Ward, 2013).

6 / 14 The disease is commonly seen in young, growing birds, particularly macaws fed excessive amounts of vitamin and mineral supplements (Schoemaker et al, 1997; Campbell-Ward, 2013).

Clinical signs include (Schoemaker et al, 1997; Campbell-Ward, 2013):

poor weight gain in growing animals depression anorexia nausea polyuria/polydipsia ataxia muscle weakness joint pain

Diagnosis is usually based on the clinical signs combined with high (ionised) blood calcium levels.

In addition, uric acid and/or vitamin D3 metabolites may be measured (Schoemaker et al, 1997; Campbell-Ward, 2013). Radiography, meanwhile, is often useful to assess bone density, renal size and detect tissue mineralisation (Schoemaker et al, 1997; Campbell-Ward, 2013).

In advanced cases, such as presence of tissue calcifications and visceral or articular gout, prognosis is generally poor.

In mild cases, prognosis may be more favourable following timely treatment with forced diuresis and dietary corrections (Schoemaker et al, 1997; Campbell-Ward, 2013).

Adrenal gland diseases

Figure 2b. In these birds, pathological fractures of the spinal column and long bones may often be seen, as shown in the radiograph (click to zoom).

7 / 14 The avian adrenal glands differ from those in mammals with regard to the lack of a distinct cortex and medulla, and the production of corticosterone rather than cortisol as the predominant glucocorticoid hormone (Oglesbee, 1997; De Matos, 2008).

Similar to other animals, disease may result from hyperfunction or hypofunction of the adrenal glands, resulting in excess, or lack of, one of the adrenal hormones (glucocorticoids, mineralocorticoids, epinephrine, norepinephrine).

Thus far, the number of birds diagnosed with spontaneous hyperadrenocorticism has been scarce (Cornelissen and Verhofstad, 1999; De Matos, 2008; Starkey et al, 2008), with only one case with an antemortem diagnosis of Cushing’s syndrome as a result of a primary adrenal gland tumour reported in a psittacine (Van Zeeland et al, 2015).

In this Senegal parrot, clinical signs included:

polyphagia polydipsia mild alopecia obesity hepatic lipidosis

Following diagnosis, which was achieved using a modified dexamethasone suppression test, the bird was successfully treated with trilostane for more than one year (Van Zeeland et al, 2015).

Aside from primary adrenal hyperfunction, hyperadrenocorticism may also result from overstimulation by a pituitary tumour or exogenous corticosteroid administration, resulting in similar signs as those described (Rae, 1995; Starkey et al, 2008).

In addition, exogenous corticosteroids exert profound effects on the immune system and may suppress both humoral and cell-mediated immunity, resulting in increased susceptibility to infections, in particular aspergillosis (Westerhof, 1997; Verstappen and Dorrestein, 2005; De Matos, 2008).

Thus far, there have been no reports documenting the presence of spontaneous hypoadrenocorticism in pet birds. It is, however, likely adrenal hypofunction occurs in these species.

Similar to other animals, adrenal cell atrophy or necrosis may be induced by neoplasia, bacterial or viral infections, immune-mediated disease, amyloidosis, trauma or drugs (for example, mitotane; Rae, 1995). Diagnosis may be achieved using an ACTH stimulation test (Lothrop et al, 1985b; Walsh et al, 1985; De Matos, 2008).

8 / 14 However, since the condition of animals with hypoadrenocorticism may quickly deteriorate as a result of hyponatraemia-associated dehydration and shock, and hyperkalaemia-associated cardiac disturbances, it is highly likely fatal complications develop too rapidly in birds without the possibility of obtaining an antemortem diagnosis or initiating appropriate treatment.

Diseases of the pancreas

In birds, glucagon, secreted by the alpha cells of the pancreatic islets, is considered the major glucose-regulating hormone, with insulin playing a less well-defined role in the glucose metabolism.

As such, glucagon excess, or inadequate insulin:glucagon ratios, rather than hypoinsulinaemia, has been proposed as the cause of avian diabetes (Sitbon et al, 1980; Hazelwood, 1984).

Histologically, destruction of beta cells (consistent with type-one diabetes in humans) has been documented in birds, with underlying causes varying from paramyxovirus or herpesvirus infections to hemochromatosis (iron storage disease; Gancz et al, 2007; Pilny, 2008).

Similarly, causes for peripheral insulin resistance (consistent with type-two diabetes), such as obesity, high levels of endogenous or exogenous corticosteroids or progestogens, and increased levels of other hormones (such as glucagon, growth hormone and epinephrine) have also been identified (Candeletta et al, 1993; Gancz et al, 2007; Pilny, 2008). Neoplasia associated with diabetes mellitus has been diagnosed in one bird (Ryan et al, 1982).

In parrots, diabetes mellitus is most commonly reported in budgerigars and cockatiels, although it may occur in larger species as well (Candeletta et al, 1993; Rae, 1995; Desmarchelier and Langlois, 2008; Gancz et al, 2007; Pilny, 2008; Campbell-Ward and Rand, 2013).

A presumptive diagnosis can usually be made based on the clinical signs (polyuria/polydipsia, weight loss despite good appetite; Figure 3) in combination with the finding of a persistent hyperglycaemia and glycosuria (Pilny, 2008; Campbell-Ward and Rand, 2013; De Matos and Monks, 2016).

The normal range for plasma glucose is significantly higher than in mammals and may range from 10mmol/L to 27.9mmol/L, dependent on the species, with values greater than 44.4mmol/L considered diagnostic for diabetes mellitus (Campbell-Ward and Rand, 2013).

Elevated fructosamine levels and/or ketonuria may also be found, supporting the diagnosis (De Matos and Monks, 2016). Furthermore, determination of plasma glucagon and insulin has been recommended, but remains challenging due to the lack of appropriately validated tests (Bonda, 1996; De Matos and Monks, 2016).

Treatment of birds with diabetes mellitus can be challenging, especially given the small size of

9 / 14 many patients and the lack of clear-cut therapeutic protocols (De Matos and Monks, 2016).

Figure 3. Polyuria and polydipsia is a common clinical finding in birds with diabetes mellitus. Similarly, polyuria/polydipsia may be seen in birds with diabetes insipidus, hyperadrenocorticism and/or pituitary tumours.

Prior to initiating treatment with glucose-regulating drugs, attempts should be made to rule out and treat any underlying or concurrent conditions. Similarly, birds may require supportive care in the form of fluids or force feeding.

In birds with persistent hyperglycaemia, treatment may be attempted with insulin and/or oral hypoglycaemic agents (such as glipizide), although the success of this treatment may vary from case to case (Bonda, 1996; Gancz et al, 2007; Pilny and Luong, 2005; Campbell-Ward and Rand, 2013; De Matos and Monks, 2016).

Hospitalisation of the bird is often recommended to enable gradual titration and regular monitoring of the patient, including serial blood glucose monitoring and urinalysis to check for glycosuria, until the bird is stable, following which treatment can continue at home (Campbell and Rand, 2013; De Matos and Monks, 2016).

Conclusion

Disorders of the endocrine system appear to be relatively rare in parrots, with the exception of goitre and secondary nutritional hyperparathyroidism, which are both linked to malnutrition.

The incidence of these diseases is likely to decrease in the future due to the increased knowledge on dietary requirements and the higher percentage of people feeding their parrots a well-balanced diet.

10 / 14 In contrast, other, less recognised endocrine diseases may be diagnosed more frequently as a result of expansion of knowledge on avian medicine and availability of diagnostic tests in birds. At the same time, more experience can be gained with proper treatment regimens for endocrine disease in birds.

Until then, knowledge on diagnosis and treatment of endocrine diseases can be extrapolated from human literature and/or companion medicine and applied to birds.

However, it is important to realise not all the information obtained from mammalian species will be applicable to birds due to the presence of anatomical and physiological differences between the two groups.

Nevertheless, the basic principles of the diagnostic work-up and therapeutic intervention for endocrine diseases in mammals offer a good starting point to clinicians confronted with a parrot suspected of an endocrine disorder.

Some drugs mentioned in this article are used under the cascade.

References

Alberts H, Halsema WB, de Bruijne JJ and Lumeij JT (1988). A water deprivation test for the differentiation of polyuric disorders in birds, Avian Pathology 17(2): 385-389. Bauck L (1988). Pituitary neoplastic disease in nine budgies, Proceedings of the Association of Avian Veterinarians, Houston: 87-89. Bonda M (1996). Plasma glucagon, serum insulin, and serum amylase levels in normal and hyperglycemic macaw, Proceedings of the Association of Avian Veterinarians, Tampa, Florida: 77-88. Campbell-Ward ML (2013). Hypercalcemia in other species, Clinical Endocrinology of Companion Animals, Wiley-Blackwell, New Jersey: 385-395. Campbell-Ward ML and Rand J (2013). Diabetes mellitus in other species, Clinical Endocrinology of Companion Animals, Wiley-Blackwell, New Jersey: 191-200. Candeletta SC, Homer BL, Garner MM and Isaza R (1993). Diabetes mellitus associated with chronic lymphocytic pancreatitis in an African grey parrot ( erithacus erithacus), Journal of the Association of Avian Veterinarians 7(1): 39-43. Cornelissen H and Verhofstad A (1999). Adrenal neoplasia in a scarlet macaw (Ara macao) with clinical signs of hyperadrenocorticism, Journal of Avian Medicine and Surgery 13(2): 92-97. Curtis-Velasco M (1992). Pituitary adenoma in a cockatiel (Nymphicus hollandicus), Journal of the Association of Avian Veterinarians 6(1): 21-22. De Matos R (2008). Adrenal steroid metabolism in birds: anatomy, physiology, and clinical considerations, Veterinary Clinics of North America: Exotic Animal Practice 11(1): 35-57. De Matos R and Monks D (2016). Diseases of the endocrine system – protein hormones. In

11 / 14 Speer BL (ed), Current Therapy in Avian Medicine and Surgery, Elsevier, St Louis: 385-399. De Wit M, Schoemaker NJ, Kik MJL and Westerhof I (2003). Hypercalcemia in two Amazon parrots with malignant lymphoma, Avian Diseases 47(1): 223-228. nanday conure (Nandayus nenday), Journal of Avian Medicine and Surgery 22(3): 246-254. Doukaki C, Kik MJL, Ducatelle R, Cornelissen H and van Zeeland YRA (2014). Thyroid adenocarcinoma in two parrots, Veterinary Record Case Reports 2(1): e000101. Gancz AY, Wellehan JFX, Boutette J, Malka S, Lee SE, Smith DA and Taylor M (2007). Diabetes mellitus concurrent with hepatic haemosiderosis in two macaws (Ara severa, Ara militaris), Avian Pathology 36(4): 331-336. Greenacre CB (2011). TSH testing in birds using canine, bovine, or human TSH, Proceedings of the Association of Avian Veterinarians, Seattle: 49. Harms CA, Hoskinson JJ, Bruyette DS, Carpenter JW and Veatch JK (1994). Technetium-99M and iodine-131 thyroid scintigraphy in normal and radiothyroidectomized cockatiels (Nymphicus hollandicus), Veterinary Radiology and Ultrasound 35(6): 473-478. Hazelwood RL (1984). Pancreatic hormones, insulin/glucagon molar ratios, and somatostatin as determinants of avian carbohydrate metabolism, Journal of Experimental Zoology 232(3): 647-652. Kritchevsky JS (2013). Hypothyroidism in other species, Clinical Endocrinology of Companion Animals, Wiley-Blackwell, New Jersey: 278-290. Latimer KS (1994). Oncology. In Ritchie BW, Harrison GJ and Harrison LR (eds), Avian Medicine: Principles and Application, Wingers Publishing, Lake Worth, Florida: 640-672. Langohr IM, Garner MM and Kiupel M (2012). Somatotroph pituitary tumors in budgerigars (Melopsittacus undulatus), Veterinary Pathology 49(3): 503-507. Lothrop CD, Loomis MR and Olsen JH (1985a). Thyrotropin stimulation test for evaluation of thyroid function in psittacine birds, Journal of the American Veterinary Medicine Association 186(1): 47-48. Lothrop CD, Olsen JH, Loomis MR, Jensen JM and Lenhard A (1985b). Evaluation of adrenal function in psittacine birds, using the ACTH stimulation test, Journal of the American Veterinary Medical Association 187(11): 1,113-1,115. Lumeij JT and Westerhof I (1988). The use of the water deprivation test for the diagnosis of apparent psychogenic polydipsia in a socially deprived African grey parrot (Psittacus erithacus erithacus), Avian Pathology 17(4): 875-878. em> 17(4): 875-878. Lumeij JT (1994). Endocrinology. In Ritchie BW, Harrison GJ and Harrison LR (eds), Avian Medicine: Principles and Application, Wingers Publishing, Lake Worth, Florida: 582-606. Oglesbee BL (1992). Hypothyroidism in a scarlet macaw, Journal of the American Veterinary Medicine Association 201(10): 1,599-1,601. Oglesbee BL (1997). Diseases of the endocrine system. In Altman RB, Clubb SG, Dorrestein GM and Quesenberry KE (eds), Avian Medicine and Surgery, WB Saunders, Philadelphia: 482-488. Orosz SE (2016). Anatomy and physiology of the endocrine system – protein hormones. In

12 / 14 Speer BL (ed), Current Therapy in Avian Medicine and Surgery, Elsevier, St Louis: 378-385. Pilny AA and Luong R (2005). Diabetes mellitus in a chestnut-fronted macaw (Ara severa), Journal of Avian Medicine and Surgery 19(4): 297-302. Pilny AA (2008). The avian pancreas in health and disease, Veterinary Clinics of North America: Exotic Animal Practice 11(1): 25-34. Rae M (1995). Endocrine disease in pet birds, Seminars in Avian and Exotic Pet Medicine 4(1): 32-38. Ritchie M and Pilny AA (2008). The anatomy and physiology of the avian endocrine system, Veterinary Clinics of North America: Exotic Animal Practice 11(1): 1-14. Romagnano A, Mashima TY, Barnes HJ, Loughman C, Degernes L and Spaulding KA (1995). Pituitary adenoma in an Amazon parrot, Journal of Avian Medicine and Surgery 9 (4): 263-270. Ryan CP, Walder EJ and Howard EB (1982). Diabetes mellitus and islet cell carcinoma in a parakeet, Journal of the American Animal Hospital Association 18: 139-142. Schlumberger HG (1954). Neoplasia in the parakeet. I. Spontaneous chromophobe pituitary tumors, Cancer Research 14(3): 237-245. Schmidt RE (2002). Avian thyroid metabolism and diseases, Seminars in Avian and Exotic Pet Medicine 11(2): 80-83. Schoemaker NJ, Lumeij JT and Beynen AC (1997). Polyuria and polydipsia due to vitamin and mineral oversupplementation of the diet of a salmon crested cockatoo (Cacatua moluccensis) and a blue and gold macaw (Ara ararauna), Avian Pathology 26(1): 201-209. Sitbon G, Laurent F, Mialhe A, Krug E, Karmann, H, Gross R, Strosser MT, Cohen L, Jean- Marie P, Foltzer C and Mialhe P (1980). Diabetes in birds, Hormone and Metabolic Research 12(1): 1-9. Stanford M (2004). The effect of UV-B lighting supplementation in African grey parrots, Exotic DVM 6(3): 57-60. Stanford M (2006). Calcium metabolism. In Harrison GJ and Lightfoot TL (eds), Clinical Avian Medicine, Spix Publishing, Palm Beach, Florida: 141-151. Stanford M (2007). Clinical pathology of hypocalcaemia in adult grey parrots (Psittacus e erithacus), Veterinary Record 161(13): 456. Stanford M, Keen J, and Campbell-Ward ML (2013). Hypocalcemia in other species, Clinical Endocrinology of Companion Animals, Wiley-Blackwell, New Jersey: 335-355. Starkey SR, Morrisey JK, Stewart JE and Buckles EL (2008). Pituitary-dependent hyperadrenocorticism in a cockatoo, Journal of the American Veterinary Medical Association 232(3): 394-398. Starkey SR, Wood C, de Matos R, Ledbetter EC and Morrisey JK (2010). Central diabetes insipidus in an African grey parrot, Journal of the American Veterinary Medical Association 237(4): 415-419. Van Zeeland YRA, Bastiaansen P, Kooistra H and Schoemaker NJ (2015). Diagnosis and treatment of Cushing’s syndrome in a Senegal parrot, Proceedings of Exoticscon, San Antonio: 119.

13 / 14 Verstappen FALM and Dorrestein GM (2005). Aspergillosis in Amazon parrots after corticosteroid therapy for smoke-inhalation injury, Journal of Avian Medicine and Surgery 19(2): 138-141. Walsh MT, Beldegreen RA, Clubb SL and Chen CL (1985). Effect of exogenous ACTH on serum corticosterone and cortisol concentrations in the Moluccan cockatoo (Cacatua moluccensis), American Journal of Veterinary Research 46(7): 1,584-1,588. Westerhof I (1997). Pituitary-adrenocortical function and glucocorticoid administration in pigeons, Veterinary Quarterly 19(Supp1): 60-61. Zenoble RD, Kemppainen RJ, Young DW and Clubb SL (1985). Endocrine response of healthy parrots to ACTH and thyroid stimulating hormone, Journal of the American Veterinary Medical Association 187(11): 1,116-1,118.

14 / 14

Powered by TCPDF (www.tcpdf.org)